US20080269153A1
(en)
*
|
2002-05-28 |
2008-10-30 |
Ruxandra Draghia-Akli |
Increased stability of a dna formulation by including poly-l-glutamate
|
US7846720B2
(en)
*
|
2005-01-26 |
2010-12-07 |
Vgx Pharmaceuticals, Inc. |
Optimized high yield synthetic plasmids
|
AU2006248646B2
(en)
*
|
2005-04-18 |
2011-04-07 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Improved methods and devices for delivering a therapeutic product to the ocular sphere of a subject
|
FR2893256B1
(fr)
*
|
2005-11-14 |
2008-08-15 |
Yves Scherman |
Generateur d'impulsions electriques unipolaires.
|
CA2635437C
(en)
*
|
2006-02-11 |
2020-01-28 |
Genetronics, Inc. |
Device and method for single-needle in vivo electroporation
|
DE102006009157B4
(de)
*
|
2006-02-24 |
2015-08-20 |
Eisenmann Ag |
Verfahren zum Aufschließen von biologischem Material sowie Vorrichtung zu seiner Durchführung
|
WO2007103070A2
(en)
*
|
2006-03-03 |
2007-09-13 |
Genetronics, Inc. |
Method and device for treating microscopic residual tumors remaining in tissues following surgical resection
|
AU2007260354B2
(en)
*
|
2006-06-12 |
2014-01-23 |
Region Hovedstaden V/Herlev Hospital |
Electrode introducer device
|
US7576549B2
(en)
*
|
2006-09-21 |
2009-08-18 |
Bio-Rad Laboratories, Inc. |
Methods for measuring sample resistance in electroporation
|
PT2066399T
(pt)
*
|
2006-10-17 |
2019-01-11 |
Inovio Pharmaceuticals Inc |
Dispositivos de eletroporação e métodos de usar os mesmos para eletroporação de células em mamíferos
|
US8524679B2
(en)
*
|
2006-11-08 |
2013-09-03 |
Veritas Bio, Llc |
In vivo delivery of double stranded RNA to a target cell
|
WO2009045813A1
(en)
*
|
2007-10-01 |
2009-04-09 |
Vgx Pharmaceuticals, Inc. |
Materials and methods for the delivery of biomolecules to cells of an organ
|
CA2705461A1
(en)
|
2007-11-12 |
2009-06-11 |
The Trustees Of The University Of Pennsylvania |
Vaccines against multiple subtypes of influenza virus
|
US8927508B2
(en)
*
|
2007-11-14 |
2015-01-06 |
Vgx Pharmaceuticals, Inc. |
Antibody production elicited by a DNA vaccine delivered by electroporation
|
MX2010007461A
(es)
|
2008-01-11 |
2010-10-20 |
VGX Pharmaceuticals LLC |
Nuevas vacunas contra multiples subtipos del virus del dengue.
|
CN101990580A
(zh)
*
|
2008-04-04 |
2011-03-23 |
宾夕法尼亚州立大学托管会 |
屈曲病毒蛋白共有序列、编码该屈曲病毒蛋白共有序列的核酸分子和组合物及其使用方法
|
CN102016023A
(zh)
*
|
2008-04-04 |
2011-04-13 |
宾夕法尼亚州立大学托管会 |
使用il-28和组合物的疫苗和免疫治疗及其使用方法
|
CA2725383C
(en)
*
|
2008-05-28 |
2018-09-25 |
Ruxandra Draghia-Akli |
Smallpox dna vaccine and the antigens therein that elicit an immune response
|
WO2010050939A1
(en)
|
2008-10-29 |
2010-05-06 |
The Trustees Of The University Of Pennsylvania |
Improved hcv vaccines and methods for using the same
|
US8921536B2
(en)
|
2008-10-29 |
2014-12-30 |
The Trustees Of The University Of Pennsylvania |
HCV vaccines and methods for using the same
|
US8961994B2
(en)
*
|
2008-11-17 |
2015-02-24 |
Vgx Pharmaceuticals, Llc |
DNA constructs eliciting immune response against flavivirus and effective adjuvants
|
TWI423790B
(zh)
*
|
2008-11-18 |
2014-01-21 |
Univ Nat Chiao Tung |
可調式電極植入系統及其可調式電極植入裝置
|
US9050287B2
(en)
|
2009-01-23 |
2015-06-09 |
The Trustees Of The University Of Pennsylvania |
Vaccines for human papilloma virus and methods for using the same
|
CA2653478A1
(en)
*
|
2009-01-23 |
2010-07-23 |
Gregg Martin |
Automated wash system for industrial vehicles
|
AU2010313132B2
(en)
|
2009-11-02 |
2015-01-15 |
Inovio Pharmaceuticals, Inc. |
Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom
|
US8298820B2
(en)
|
2010-01-26 |
2012-10-30 |
The Trustees Of The University Of Pennsylvania |
Influenza nucleic acid molecules and vaccines made therefrom
|
US9034313B2
(en)
|
2010-02-08 |
2015-05-19 |
The Trustees Of The University Of Pennsylvania |
Nucleic acid molecules encoding rantes, and compositions comprising and methods of using the same
|
BR112013007051A2
(pt)
|
2010-09-27 |
2019-07-02 |
Inovio Pharmaceuticals Inc [Us/Is] |
construções de antígenio de consenso e vacinas feitas dos mesmos e métodos de uso das mesmas para tratar a malária
|
US8927692B2
(en)
|
2010-11-12 |
2015-01-06 |
The Trustees Of The University Of Pennsylvania |
Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same
|
EP4349211A3
(en)
|
2011-01-28 |
2024-06-12 |
The General Hospital Corporation |
Method and appratus for skin resurfacing
|
EP2667805B1
(en)
|
2011-01-28 |
2023-04-05 |
The General Hospital Corporation |
Apparatus and method for tissue biopsy
|
CN106913371B
(zh)
|
2011-01-28 |
2019-12-10 |
通用医疗公司 |
用于不连续皮肤磨削的方法和装置
|
KR20140007404A
(ko)
|
2011-01-31 |
2014-01-17 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
신규 허피스 항원을 암호화하는 핵산 분자, 이것을 포함하는 백신 및 이것의 사용 방법
|
US9238679B2
(en)
|
2011-02-11 |
2016-01-19 |
The Trustees Of The University Of Pennslyvania |
Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same
|
EA202092990A3
(ru)
|
2011-02-11 |
2021-07-30 |
Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания |
Молекула нуклеиновой кислоты, кодирующая коровый белок вируса гепатита в, и вакцина, содержащая указанную молекулу
|
ITTO20110374A1
(it)
*
|
2011-04-29 |
2012-10-30 |
Igea S P A |
Metodo di controllo di un dispositivo di elettro-porazione
|
EP3662935A1
(en)
|
2011-07-11 |
2020-06-10 |
Inovio Pharmaceuticals, Inc. |
Cross-protective arenavirus vaccines and their method of use
|
EP2741785B1
(en)
|
2011-07-12 |
2018-09-05 |
Philadelphia Health and Education Corporation |
Novel clostridium difficile dna vaccine
|
US20140277055A1
(en)
|
2011-07-21 |
2014-09-18 |
The General Hospital Corporation |
Method and apparatus for damage and removal of fat
|
SG11201400527XA
(en)
|
2011-09-16 |
2014-04-28 |
Univ Pennsylvania |
Rna engineered t cells for the treatment of cancer
|
WO2013044225A1
(en)
|
2011-09-22 |
2013-03-28 |
The Trustees Of The University Of Pennsylvania |
A universal immune receptor expressed by t cells for the targeting of diverse and multiple antigens
|
WO2013055326A2
(en)
|
2011-10-12 |
2013-04-18 |
The Trustees Of The University Of Pennsylvania |
Vaccines for human papilloma virus and methods for using the same
|
KR101913674B1
(ko)
|
2011-10-24 |
2018-10-31 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
개선된 hcv 백신 및 이것을 사용하는 방법
|
WO2013063419A2
(en)
|
2011-10-28 |
2013-05-02 |
The Trustees Of The University Of Pennsylvania |
A fully human, anti-mesothelin specific chimeric immune receptor for redirected mesothelin-expressing cell targeting
|
EA026926B1
(ru)
|
2011-12-12 |
2017-05-31 |
Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания |
Композиции, содержащие улучшенные генетические конструкции il-12, вакцины, иммунотерапевтические составы и способы их применения
|
JP6407028B2
(ja)
|
2011-12-12 |
2018-10-17 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
MRSAのPBP2a及びその断片を含むタンパク質、それをコードする核酸、並びにMRSA感染を予防する及び治療するための組成物及びそれらの使用
|
SG11201404284SA
(en)
|
2012-02-22 |
2014-10-30 |
Univ Pennsylvania |
Use of the cd2 signaling domain in second-generation chimeric antigen receptors
|
WO2013126733A1
(en)
|
2012-02-22 |
2013-08-29 |
The Trustees Of University Of Pennsylvania |
Use of icos-based cars to enhance antitumor activity and car persistence
|
US10040828B2
(en)
|
2012-04-10 |
2018-08-07 |
The Trustees Of The University Of Pennsylvania |
Human respiratory syncytial virus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same
|
KR102351881B1
(ko)
|
2012-04-12 |
2022-01-18 |
더 트러스티스 오브 더 유니버시티 오브 펜실베니아 |
필로바이러스 공통 항원, 이로부터 제조된 핵산 구조체 및 백신, 및 이를 사용하는 방법
|
EP3730512A1
(en)
|
2012-07-13 |
2020-10-28 |
The Trustees of the University of Pennsylvania |
Enhancing activity of car t cells by co-introducing a bispecific antibody
|
EP2904106A4
(en)
|
2012-10-01 |
2016-05-11 |
Univ Pennsylvania |
COMPOSITIONS AND METHODS FOR TARGETING STROMAL CELLS FOR THE TREATMENT OF CANCER
|
US9598489B2
(en)
|
2012-10-05 |
2017-03-21 |
The Trustees Of The Univeristy Of Pennsylvania |
Human alpha-folate receptor chimeric antigen receptor
|
WO2014055657A1
(en)
|
2012-10-05 |
2014-04-10 |
The Trustees Of The University Of Pennsylvania |
Use of a trans-signaling approach in chimeric antigen receptors
|
WO2014066655A2
(en)
*
|
2012-10-25 |
2014-05-01 |
Oncosec Medical Incorporation |
Electroporation device
|
CN104812401B
(zh)
|
2012-12-13 |
2017-10-13 |
宾夕法尼亚大学理事会 |
Wt1疫苗
|
CA2900505C
(en)
|
2013-02-20 |
2023-10-24 |
Cytrellis Biosystems, Inc. |
Methods and devices for skin tightening
|
KR20150130438A
(ko)
|
2013-03-12 |
2015-11-23 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
인간 파밀로마 바이러스용 개선된 백신 및 이것을 사용하는 방법
|
ES2817903T3
(es)
|
2013-03-15 |
2021-04-08 |
Univ Pennsylvania |
Proteínas de consenso del virus de la Fiebre Aftosa (VFA), secuencias codificantes y vacunas preparadas a partir de las mismas
|
AU2014228405B2
(en)
|
2013-03-15 |
2017-05-11 |
The Trustees Of The University Of Pennsylvania |
Cancer vaccines and methods of treatment using the same
|
US11013917B2
(en)
|
2013-06-21 |
2021-05-25 |
Newsouth Innovations Pty Limited |
Method and apparatus for close-field electroporation
|
KR102349218B1
(ko)
|
2013-08-09 |
2022-01-10 |
사이트렐리스 바이오시스템즈, 인크. |
비-열적 조직 절제를 사용한 피부 치료를 위한 방법 및 기구
|
CN203451533U
(zh)
*
|
2013-08-27 |
2014-02-26 |
苏州文曲生物微系统有限公司 |
一种基于新型微电极芯片的电穿孔系统
|
EP3080159A4
(en)
|
2013-12-13 |
2017-08-02 |
The Trustees Of The University Of Pennsylvania |
Dna antibody constructs and method of using same
|
WO2015095675A1
(en)
|
2013-12-19 |
2015-06-25 |
Cytrellis Biosystems, Inc. |
Methods and devices for manipulating subdermal fat
|
US11028143B2
(en)
|
2014-01-21 |
2021-06-08 |
Novartis Ag |
Enhanced antigen presenting ability of RNA CAR T cells by co-introduction of costimulatory molecules
|
EP3215168B1
(en)
|
2014-10-31 |
2023-08-02 |
The Trustees of the University of Pennsylvania |
Altering gene expression in modified t cells and uses thereof
|
US11471487B2
(en)
|
2014-10-31 |
2022-10-18 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods of stimulating and expanding T cells
|
CA2967636A1
(en)
|
2014-11-14 |
2016-05-19 |
Cytrellis Biosystems, Inc. |
Devices and methods for ablation of the skin
|
CA2969214A1
(en)
|
2014-12-01 |
2016-06-09 |
The Trustees Of The University Of Pennsylvania |
Dna antibody constructs and method of using same
|
CA2973390A1
(en)
|
2015-01-09 |
2016-07-14 |
Oncosec Medical Incorporated |
Method for the treatment of malignancies
|
AU2015380397B2
(en)
|
2015-01-31 |
2021-10-21 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for T cell delivery of therapeutic molecules
|
PL3286311T3
(pl)
|
2015-03-26 |
2021-09-13 |
Oncosec Medical Incorporated |
Sposób leczenia nowotworów złośliwych
|
CA2981474A1
(en)
|
2015-03-31 |
2016-10-06 |
Oncosec Medical Incorporated |
Systems and methods for improved tissue-sensing based electroporation
|
RU2754661C2
(ru)
|
2015-05-01 |
2021-09-06 |
Дзе Реджентс Оф Дзе Юниверсити Оф Калифорния |
Гликанзависимые иммунотерапевтические молекулы
|
NZ737871A
(en)
|
2015-06-25 |
2023-02-24 |
Newsouth Innovations Pty Ltd |
Electroporation system for controlled localized therapeutics delivery
|
CN108348551A
(zh)
|
2015-08-28 |
2018-07-31 |
宾夕法尼亚大学董事会 |
表达嵌合细胞内信号传导分子的细胞的方法和组合物
|
KR101788301B1
(ko)
*
|
2015-09-17 |
2017-10-20 |
주식회사 엘림텍 |
전기천공장치 및 그 제어방법
|
KR20190031424A
(ko)
|
2015-12-18 |
2019-03-26 |
온코섹 메디컬 인코포레이티드 |
이종 단백질 발현을 위한 플라스미드 작제물 및 사용 방법
|
DK3393575T3
(da)
*
|
2015-12-22 |
2024-04-15 |
Inovio Pharmaceuticals Inc |
Elektroporationsanordning med en batterienhed med strømafbryder
|
JP7123800B2
(ja)
|
2016-02-05 |
2022-08-23 |
イノビオ ファーマシューティカルズ,インコーポレイティド |
がんのワクチン及びそれを用いた処置の方法
|
EP3432924A1
(en)
|
2016-03-23 |
2019-01-30 |
Novartis AG |
Cell secreted minibodies and uses thereof
|
KR102561605B1
(ko)
|
2016-03-29 |
2023-08-01 |
사이트렐리스 바이오시스템즈, 인크. |
미용 피부 리설페이싱용 디바이스 및 방법
|
EP3443107A1
(en)
|
2016-04-13 |
2019-02-20 |
Synthetic Genomics, Inc. |
Recombinant arterivirus replicon systems and uses thereof
|
JP2018035137A
(ja)
|
2016-07-13 |
2018-03-08 |
マブイミューン ダイアグノスティックス エイジーMabimmune Diagnostics Ag |
新規な抗線維芽細胞活性化タンパク質(fap)結合薬剤およびその使用
|
AU2017330298B2
(en)
|
2016-09-21 |
2022-09-29 |
Cytrellis Biosystems, Inc. |
Devices and methods for cosmetic skin resurfacing
|
EP3526332B1
(en)
|
2016-10-17 |
2024-06-26 |
Janssen Pharmaceuticals, Inc. |
Recombinant virus replicon systems and uses thereof
|
JP2020500536A
(ja)
|
2016-12-05 |
2020-01-16 |
シンセティック ジェノミクス インコーポレーテッド |
遺伝子発現増強のための組成物および方法
|
GB201710973D0
(en)
|
2017-07-07 |
2017-08-23 |
Avacta Life Sciences Ltd |
Scaffold proteins
|
SE541651C2
(en)
|
2017-07-28 |
2019-11-19 |
Scandinavian Chemotech Ab |
An electrode device and a needle electrode for use in delivery of electrical pulses to a desired tissue of a mammal
|
ES2938900T3
(es)
|
2017-12-13 |
2023-04-17 |
Inovio Pharmaceuticals Inc |
Vacunas contra el cáncer dirigidas al PRAME y usos de las mismas
|
EP3723812A4
(en)
|
2017-12-13 |
2022-02-16 |
Inovio Pharmaceuticals, Inc. |
MUC16-TARGETING CANCER VACCINES AND THEIR USES
|
JP7352547B2
(ja)
|
2017-12-13 |
2023-09-28 |
イノビオ ファーマシューティカルズ,インコーポレイティド |
メソセリンを標的とするがんワクチンおよびその使用
|
MX2020006471A
(es)
|
2017-12-19 |
2020-09-22 |
Janssen Sciences Ireland Unlimited Co |
Metodos y composiciones para inducir una respuesta inmune contra el virus de hepatitis b (hbv).
|
US11389531B2
(en)
|
2017-12-19 |
2022-07-19 |
Janssen Sciences Ireland Unlimited Company |
Methods and apparatus for the delivery of hepatitis B virus (HBV) vaccines
|
EA202091516A1
(ru)
|
2017-12-19 |
2020-11-03 |
Янссен Сайенсиз Айрлэнд Анлимитед Компани |
Способы и композиции для индукции иммунного ответа против вируса гепатита b (hbv)
|
EA202091513A1
(ru)
|
2017-12-19 |
2020-09-09 |
Янссен Сайенсиз Айрлэнд Анлимитед Компани |
Вакцины против вируса гепатита b (hbv) и их применение
|
WO2019123252A1
(en)
|
2017-12-19 |
2019-06-27 |
Janssen Sciences Ireland Unlimited Company |
Hepatitis b virus (hbv) vaccines and uses thereof
|
CA3086267A1
(en)
|
2017-12-29 |
2019-07-04 |
Cellectis |
Method for improving production of car t cells
|
KR20200111729A
(ko)
|
2018-01-19 |
2020-09-29 |
얀센 파마슈티칼즈, 인코포레이티드 |
재조합 레플리콘 시스템을 이용한 면역 반응 유도 및 증진
|
WO2020092455A2
(en)
|
2018-10-29 |
2020-05-07 |
The Broad Institute, Inc. |
Car t cell transcriptional atlas
|
US11185692B2
(en)
*
|
2018-10-31 |
2021-11-30 |
Emily Ireland |
Light touch therapeutic headset
|
US11071860B2
(en)
|
2019-02-06 |
2021-07-27 |
Oncosec Medical Incorporated |
Systems and methods for detecting fault conditions in electroporation therapy
|
WO2020191102A1
(en)
|
2019-03-18 |
2020-09-24 |
The Broad Institute, Inc. |
Type vii crispr proteins and systems
|
US11090336B2
(en)
|
2019-03-27 |
2021-08-17 |
The Trustees Of The University Of Pennsylvania |
Tn-MUC1 chimeric antigen receptor (CAR) T cell therapy
|
US11660139B2
(en)
|
2019-04-10 |
2023-05-30 |
Radioclash Inc. |
Electroporation probe
|
CN109999340B
(zh)
*
|
2019-04-29 |
2024-07-16 |
杭州睿笛生物科技有限公司 |
一种负载自适应纳秒脉冲产生装置
|
WO2020255014A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Recombinant interleukin 12 construct and uses thereof
|
US20220305116A1
(en)
|
2019-06-18 |
2022-09-29 |
Janssen Sciences lreland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and capsid assembly modulators being sulfonamide derivatives
|
MA56533A
(fr)
|
2019-06-18 |
2022-04-27 |
Janssen Sciences Ireland Unlimited Co |
Combinaison de vaccins contre le virus de l'hépatite b (vhb) et d'anticorps anti-pd-1
|
WO2020255019A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and a quinazoline derivative
|
US20220305117A1
(en)
|
2019-06-18 |
2022-09-29 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and hbv-targeting rnai
|
WO2020254876A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Virus-like particle delivery of hepatitis b virus (hbv) vaccines
|
AU2020297008A1
(en)
|
2019-06-18 |
2022-02-17 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis B virus (HBV) vaccines and HBV-targeting RNAi
|
CA3140690A1
(en)
|
2019-06-18 |
2020-12-24 |
Helen Horton |
Combination of hepatitis b virus (hbv) vaccines and dihydropyrimidine derivatives as capsid assembly modulators
|
US20220324916A1
(en)
|
2019-06-18 |
2022-10-13 |
Janssen Sciences Ireland Unlimited Company |
Hepatitis B Virus (HBV) Vaccines and Uses Thereof
|
CA3140708A1
(en)
|
2019-06-18 |
2020-12-24 |
Helen Horton |
Combination of hepatitis b virus (hbv) vaccines and pyridopyrimidine derivatives
|
WO2020255020A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and pd-l1 inhibitors
|
WO2020255022A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and aminopyridine derivatives as hpk1 inhibitors
|
WO2020255035A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and pyrimidine derivatives
|
CA3143680A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and anti-pd-1 or anti-pd-l1 antibody
|
CA3140707A1
(en)
|
2019-06-18 |
2020-12-24 |
Helen Horton |
Combination of hepatitis b virus (hbv) vaccines and quinazoline derivatives
|
WO2020255016A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and dihydropyrimidine derivatives as capsid assembly modulators
|
WO2020255013A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and capsid assembly modulators being amide derivatives
|
CA3140588A1
(en)
|
2019-06-18 |
2020-12-24 |
Helen Horton |
Combination of hepatitis b virus (hbv) vaccines and small molecule pdl1 or pd1 inhibitor
|
WO2020255042A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and a pyrimidine derivative
|
WO2020255010A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of recombinant interleukin 12 construct and hepatitis b virus (hbv) vaccines
|
US20220233526A1
(en)
|
2019-06-18 |
2022-07-28 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and dihydropyrimidine derivatives as capsid assembly modulators
|
MA56534A
(fr)
|
2019-06-20 |
2022-04-27 |
Janssen Sciences Ireland Unlimited Co |
Administration par nanoporteurs glucidiques, de vaccins contre le virus de l'hépatite b (vhb)
|
WO2020255062A1
(en)
|
2019-06-20 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Lipid nanoparticle or liposome delivery of hepatitis b virus (hbv) vaccines
|
TW202120551A
(zh)
|
2019-08-12 |
2021-06-01 |
美商普瑞諾生物科技公司 |
藉由adcc靶向cd39表現細胞促進及增強t細胞介導免疫反應之方法及組合物
|
TW202128775A
(zh)
|
2019-10-16 |
2021-08-01 |
英商阿法克塔生命科學有限公司 |
PD-L1抑制劑-TGFβ抑制劑雙特異性藥物部分
|
CA3174103A1
(en)
|
2020-03-06 |
2021-09-10 |
Go Therapeutics, Inc. |
Anti-glyco-cd44 antibodies and their uses
|
CA3172449A1
(en)
|
2020-03-27 |
2021-09-30 |
Erik Hans MANTING |
Ex vivo use of modified cells of leukemic origin for enhancing the efficacy of adoptive cell therapy
|
WO2021191871A1
(en)
|
2020-03-27 |
2021-09-30 |
Dcprime B.V. |
In vivo use of modified cells of leukemic origin for enhancing the efficacy of adoptive cell therapy
|
GB202101299D0
(en)
|
2020-06-09 |
2021-03-17 |
Avacta Life Sciences Ltd |
Diagnostic polypetides and methods
|
US20230272378A1
(en)
|
2020-06-12 |
2023-08-31 |
University Of Rochester |
ENCODING AND EXPRESSION OF ACE-tRNAs
|
BR112022027038A2
(pt)
|
2020-07-08 |
2023-01-24 |
Janssen Sciences Ireland Unlimited Co |
Vacinas de replicon de rna contra hbv
|
US20230372484A1
(en)
|
2020-09-14 |
2023-11-23 |
Vor Biopharma Inc. |
Chimeric antigen receptors for treatment of cancer
|
CA3196677A1
(en)
|
2020-11-05 |
2022-05-12 |
Erik Hans MANTING |
Use of tumor-independent antigens in immunotherapies
|
WO2022133230A1
(en)
|
2020-12-18 |
2022-06-23 |
Janssen Pharmaceuticals, Inc. |
Combination therapy for treating hepatitis b virus infection
|
WO2022146654A1
(en)
|
2020-12-28 |
2022-07-07 |
Janssen Pharmaceuticals, Inc. |
Transcription activator-like effector nucleases (talens) targeting hbv
|
WO2022187591A1
(en)
|
2021-03-05 |
2022-09-09 |
Go Therapeutics, Inc. |
Anti-glyco-cd44 antibodies and their uses
|
KR20230157388A
(ko)
|
2021-03-12 |
2023-11-16 |
멘두스 비.브이. |
백신접종의 방법 및 cd47 차단의 용도
|
JP2024522909A
(ja)
*
|
2021-06-30 |
2024-06-21 |
イノビオ ファーマシューティカルズ,インコーポレイティド |
電気穿孔のための電極アレイ、並びに関連するシステム及び方法
|
WO2023010118A1
(en)
|
2021-07-29 |
2023-02-02 |
Vor Biopharma Inc. |
Nfat-responsive reporter systems for assessing chimeric antigen receptor activation and methods of making and using the same
|
EP4376877A2
(en)
|
2021-07-29 |
2024-06-05 |
Vor Biopharma Inc. |
Chimeric antigen receptors for treatment of cancer
|
AU2022324456A1
(en)
|
2021-08-05 |
2024-02-15 |
Go Therapeutics, Inc. |
Anti-glyco-muc4 antibodies and their uses
|
KR20240101546A
(ko)
|
2021-09-03 |
2024-07-02 |
고 테라퓨틱스, 인크. |
항-글리코-lamp1 항체 및 그의 용도
|
CN118354789A
(zh)
|
2021-09-03 |
2024-07-16 |
Go医疗股份有限公司 |
抗糖-cMET抗体及其用途
|
WO2023150753A1
(en)
|
2022-02-07 |
2023-08-10 |
University Of Rochester |
Optimized sequences for enhanced trna expression or/and nonsense mutation suppression
|
WO2023215874A1
(en)
*
|
2022-05-05 |
2023-11-09 |
Renbio, Inc. |
Device related to therapeutic dna delivery
|
US20240002800A1
(en)
|
2022-05-16 |
2024-01-04 |
Mendus B.V. |
Use of leukemia-derived cells for enhancing natural killer (nk) cell therapy
|
WO2023233290A1
(en)
|
2022-05-31 |
2023-12-07 |
Janssen Sciences Ireland Unlimited Company |
Rnai agents targeting pd-l1
|
WO2024129459A1
(en)
|
2022-12-16 |
2024-06-20 |
University Of Rochester |
Repairmen! of barrier dysfunction in esophagus
|